Samir Kapadia, MD, is the Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular Thoracic Institute at Cleveland Clinic. He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Kapadia is board-certified in internal medicine, cardiology, and interventional cardiology. Dr. Kapadia received his medical degree with honors from Smt. NHL Municipal Medical College in Gujarat, India. He completed his internship and residency in internal medicine at Baylor College of Medicine, Houston, where he was named Outstanding Resident.
Dr. Kapadia completed fellowships in cardiology and interventional cardiology at Cleveland Clinic, Cleveland, and was named Chief Interventional Fellow. Dr. Kapadia was appointed to Cleveland Clinic in 2003 as a Staff Interventional Cardiologist. Prior to his appointment to Cleveland Clinic, Dr. Kapadia had an academic appointment to the Department of Medicine at the University of Washington, Seattle, and was an Interventional Cardiologist at the VA Puget Sound Health Care System, Seattle. Dr. Kapadia has more than 900 peer reviewed publications in the techniques and outcomes of percutaneous therapies for valvular heart disease, coronary artery disease, as well as other structural heart problems. He spearheaded the research on stroke prevention in patients undergoing TAVR. He is currently the principal investigator in a number of clinical research trials, including research to investigate percutaneous methods to treat aortic stenosis and mitral regurgitation.
Dr. Kapadia has authored two text books, the Textbook of Interventional Cardiology and Board Review for Cardiology. He has been an invited speaker at hundreds of regional, national and international symposia and conferences. He has been involved in several guidelines and position papers on percutaneous treatment of valvular heart disease.